No, other things would move the needle. Breakthrough designation. First good results from the CRC trial (open study). Maybe even preclinical Glioblastoma.
(11)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.